ABS course Map
-
desktop_windows
CDK4 and other advances in hormone positive cancers
Professor Richard Simcock | ABS Conference 2024
14.05.2024 | Added: 29.07.2024
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Endocrine therapy
desktop_windowsWebcast desktop_windows -
menu_book
MonarchE is an open-label, randomised, phase 3 trial which recruited high risk hormone receptor positive, HER2 receptor negative, node-positive breast cancer patients (n=5637). Patients were randomise...
Prof Stephen R D Johnston, MD et al | The Lancet Oncology
06.12.2022 | Added: 06.12.2022
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Adjuvant treatment Endocrine therapy Trials
menu_bookPublication menu_book -
desktop_windows
Compliance with adjuvant endocrine therapy and management of side effects
Ann Partridge | ABS Conference 2022
16.05.2022 | Added: 16.05.2022
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Endocrine Therapy
desktop_windowsWebcast desktop_windows -
desktop_windows
Supporting women with adherence to endocrine therapy
Linda Sharp & Eila Watson | ABS Conference 2022
16.05.2022 | Added: 16.05.2022
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Endocrine Therapy
desktop_windowsWebcast desktop_windows -
menu_book
Radiotherapy omission is considered in women >70 years old with ER+ T1N0 tumour post-BCS if the patient receives endocrine therapy (ET). However, the impact of poor adherence to ET on locoregional rec...
Regina Matar MD et al | Annals of Surgical Oncology
24.04.2022 | Added: 24.04.2022
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Radiotherapy Management of the older patient
menu_bookPublication menu_book -
menu_book
This EBCTCG meta-analysis investigated whether pre-menopausal women treated with ovarian suppression benefited from aromatase inhibitors (AIs). Meta-analysis was performed from individual patient data...
n/a | National Library of Medicine
23.03.2022 | Added: 23.03.2022
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Endocrine Therapy
menu_bookPublication menu_book -
list
Updated recommendations regarding the management of older patients with breast cancer
The European Society of Breast Cancer Specialists (EUSOMA) and The International Society of Geriatric Oncology (SIOG) have produced a useful document outlining the evidence based management of older p...
European Society of Breast Cancer Specialists (EUSOMA) & International Society of Geriatric Oncology (SIOG) | Italy & France
21.08.2021 | Added: 21.08.2021
Classifications: Breast Cancer Treatment
Keywords: Management of the older patient
listGuideline list -
menu_book
Duration of adjuvant aromatase-inhibitor therapy in postmenopausal breast cancer
This prospective randomised trial assigned postmenopausal women with HR-positive breast cancer who had received 5 years of adjuvant endocrine therapy (n=3484) to receive either additional 2 or 5 years...
Michael Gnant et al | The New England Journal of Medicine
28.07.2021 | Added: 28.07.2021
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Endocrine Therapy
menu_bookPublication menu_book -
desktop_windows
Neoadjuvant Endocrine Treatment
ABS | ABS Conference 2021
17.05.2021 | Added: 17.05.2021
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Endocrine therapy
desktop_windowsWebcast desktop_windows -
menu_book
This was a multicentre, prospective, observational cohort study of surgery or primary endocrine therapy in women aged over 70 years with operable breast cancer (n=3416 with 56 UK breast units who part...
J L M Morgan et al | British Journal of Surgery
24.03.2021 | Added: 24.03.2021
Classifications: Breast Cancer Treatment
Keywords: Management of the older patient
menu_bookPublication menu_book -
list
Endocrine treatment for breast cancer
ABS have produced an up to date guideline on endocrine therapy for early breast cancer patients
Association of Breast Surgery, UK
21.01.2021 | Added: 21.01.2021
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Endocrine therapy
listGuideline list -
Oncology update on adjuvant extended endocrine treatment and adjuvant bisphosphonates
Dr Catherine Harper-Wynne | ABS Conference 2019
13.05.2019 | Added: 13.05.2019
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Endocrine therapy Bisphosphonates
-
desktop_windows
Enhancing response to neoadjuvant Letrozole: The PALLET trial
Prof Stephen Johnston | ABS Conference 2019
13.05.2019 | Added: 13.05.2019
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Endocrine therapy Trials
desktop_windowsWebcast desktop_windows -
list
Early and locally advanced breast cancer: diagnosis and treatment
NICE have updated their guidance on the management of early breast cancer to take into account developments since the 2009 iteration of this guidance. They recommend re-excision of breast tissue shoul...
National Institute for Health and Care Excellence (NICE), UK | United Kingdom
18.08.2018 | Added: 18.08.2018
Classifications: Breast Cancer Treatment Service Guidance
Keywords: Early Breast Cancer Locally Advanced Breast Cancer
listGuideline list -
desktop_windows
Ms Shelley Potter | ABS Conference 2018
18.06.2018 | Added: 18.06.2018
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Endocrine therapy
desktop_windowsWebcast desktop_windows -
desktop_windows
Neoadjuvant endocrine therapy; effect on phenotype and molecular profile in luminal breast carcinoma
Nahla Badr | ABS Conference 2018
18.06.2018 | Added: 18.06.2018
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Neoadjuvant Chemotherapy/ NACT
desktop_windowsWebcast desktop_windows -
desktop_windows
Mr Robert Thomas | ABS Conference 2017
15.05.2017 | Added: 15.05.2017
Classifications: Adjuvant & Neoadjuvant Treatment
desktop_windowsWebcast desktop_windows -
desktop_windows
Should all hormone receptor positive breast cancer patients be offered extended endocrine therapy?
Prof John Benson | ABS Conference 2017
15.05.2017 | Added: 15.05.2017
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Endocrine therapy
desktop_windowsWebcast desktop_windows